Alpha-blocker and NSAID combination

This page covers all Alpha-blocker and NSAID combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1 adrenergic receptor; COX-1 and COX-2 enzymes.

Targets

Alpha-1 adrenergic receptor; COX-1 and COX-2 enzymes

Marketed (1)

• alpha-blocker and NSAID · Samsung Medical Center · Urology
  This combination blocks alpha-adrenergic receptors to relax smooth muscle in the urinary tract while inhibiting cyclooxygenase enzymes to reduce inflammation and pain.

Patent intelligence

• alpha blocker and nsaid combination patent landscape — aggregated cliff calendar, attackable patents, originator estates